These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar

Accenture's most accurate EPS estimate is $3.20 versus the $3.19 consensus, implying a +0.33% Earnings ESP ahead of its October 1, 2026 earnings release. DocuSign's $1.18 most accurate estimate versus $1.16 consensus implies a larger +1.05% ESP ahead of its December 3, 2026 report. Both companies carry Zacks Rank #3 (Hold), with the positive ESP signals indicating a modestly improved probability of beating quarterly expectations rather than a confirmed earnings catalyst.

Analysis

This is not independently actionable information: the estimate differentials are too small to establish an earnings-information edge and are particularly vulnerable to normal consensus-data timing noise. For ACN, the relevant issue is not a modest EPS beat but whether bookings, large-deal conversion and generative-AI services monetization can support FY27 revenue and operating-margin expectations; a beat without raised forward guidance is more likely to produce a sell-the-news reaction. The near-term read-through is broader consulting demand: weak discretionary transformation spending would weigh more on ACN than on IT-services peers with larger managed-services or cost-takeout exposure, including IBM and CTSH.

DOCU has a more asymmetric event setup because its valuation depends on whether product expansion can offset mature e-signature growth and sustain billings/retention. A small EPS upside driven by expense discipline would not validate the multiple; investors should focus on billings, net retention, enterprise penetration and guidance. Over 6-18 months, AI-enabled contract lifecycle management is both an upsell opportunity and a competitive risk, with MSFT, ADBE and CRM able to bundle adjacent workflow tools into existing enterprise seats.

Contrarian view: the likely consensus error is treating an accounting beat as a demand signal. The better trade is to wait for evidence in forward bookings and guidance, since both companies can exceed quarterly EPS through cost controls while their longer-duration revenue assumptions deteriorate. The stated research signal should be treated as a sentiment watch item, not a standalone catalyst.

Key Decisions for Investors

• No pre-earnings directional position in ACN solely on this signal; monitor consensus FY27 revenue and EPS revisions through the report. Consider a 1-3 month long only if management raises full-year revenue or bookings expectations and the stock holds the post-results move; exit if forward revenue guidance is unchanged or reduced.
• For ACN earnings, prefer a defined-risk post-event relative-value setup: long ACN / short CTSH only if ACN demonstrates accelerating large-deal bookings and CTSH does not. Size for a 5-7% adverse relative move; the thesis is falsified by comparable bookings weakness or a broad IT-services demand downgrade.
• Keep DOCU on an earnings watch list rather than buying 77 days ahead of results. Initiate only after evidence that billings and net retention improve alongside raised guidance; otherwise, a short DOCU versus long ADBE or MSFT is the cleaner 3-6 month expression of bundling and platform-competition risk.
• Before either event, compare implied volatility with each name's historical post-earnings move. If implied moves materially exceed history without corroborating estimate revisions from multiple analysts, selling defined-risk premium structures may be preferable to taking earnings direction.